BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10049744)

  • 1. Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation.
    Russell-Harde D; Wagner TC; Perez HD; Croze E
    Biochem Biophys Res Commun; 1999 Feb; 255(2):539-44. PubMed ID: 10049744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers.
    Lamken P; Lata S; Gavutis M; Piehler J
    J Mol Biol; 2004 Jul; 341(1):303-18. PubMed ID: 15312780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.
    Arduini RM; Strauch KL; Runkel LA; Carlson MM; Hronowski X; Foley SF; Young CN; Cheng W; Hochman PS; Baker DP
    Protein Sci; 1999 Sep; 8(9):1867-77. PubMed ID: 10493588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
    Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
    Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.
    Marijanovic Z; Ragimbeau J; van der Heyden J; Uzé G; Pellegrini S
    Biochem J; 2007 Oct; 407(1):141-51. PubMed ID: 17627610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
    Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
    J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
    Piehler J; Schreiber G
    J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in the unstructured C-terminal tail of interferons contribute to differential receptor binding and biological activity.
    Slutzki M; Jaitin DA; Yehezkel TB; Schreiber G
    J Mol Biol; 2006 Jul; 360(5):1019-30. PubMed ID: 16815442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared receptor components but distinct complexes for alpha and beta interferons.
    Lewerenz M; Mogensen KE; Uzé G
    J Mol Biol; 1998 Sep; 282(3):585-99. PubMed ID: 9737924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-viral proteins: from interferon alpha to its receptor].
    Chieux V; Hober D; Chehadeh W; Wattr P
    Ann Biol Clin (Paris); 1999 May; 57(3):283-90. PubMed ID: 10377478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IFNAR1 subunit of the type I IFN receptor complex contains a functional nuclear localization sequence.
    Subramaniam PS; Johnson HM
    FEBS Lett; 2004 Dec; 578(3):207-10. PubMed ID: 15589821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
    Khine AA; Lingwood CA
    J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-alpha signaling complex.
    Walters DK; French JD; Arendt BK; Jelinek DF
    Oncogene; 2003 Jun; 22(23):3598-607. PubMed ID: 12789268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR backbone dynamics of the human type I interferon binding subunit, a representative cytokine receptor.
    Chill JH; Quadt SR; Anglister J
    Biochemistry; 2004 Aug; 43(31):10127-37. PubMed ID: 15287740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential use of the betaL subunit of the type I interferon (IFN) receptor determines signaling specificity for IFNalpha2 and IFNbeta.
    Domanski P; Nadeau OW; Platanias LC; Fish E; Kellum M; Pitha P; Colamonici OR
    J Biol Chem; 1998 Feb; 273(6):3144-7. PubMed ID: 9452423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
    Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G
    Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for Janus kinases in crosstalk between ErbB3 and the interferon-alpha signaling complex in myeloma cells.
    Walters DK; Jelinek DF
    Oncogene; 2004 Feb; 23(6):1197-205. PubMed ID: 14647450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping human interferon-alpha (IFN-alpha 2) binding determinants of the type I interferon receptor subunit IFNAR-1 with human/bovine IFNAR-1 chimeras.
    Goldman LA; Cutrone EC; Dang A; Hao X; Lim JK; Langer JA
    Biochemistry; 1998 Sep; 37(37):13003-10. PubMed ID: 9737881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein.
    Croze E; Russell-Harde D; Wagner TC; Pu H; Pfeffer LM; Perez HD
    J Biol Chem; 1996 Dec; 271(52):33165-8. PubMed ID: 8969169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-type-I-mediated signaling is regulated by modulation of STAT2 nuclear export.
    Frahm T; Hauser H; Köster M
    J Cell Sci; 2006 Mar; 119(Pt 6):1092-104. PubMed ID: 16507591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.